Skip to main content

BIOX · Bioceres Crop Solutions Corp. · Metrics

Track BIOX — free
$0.42 0.00 (-0.91%) At close · Sep 10
Market Cap
$26.17M
Shares
63.82M

BIOX metrics

64 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.42
Market cap
$26.17M

Price action

20 metrics
Price change (1W)
-4.6%
Price change (30D)
+18.8%
Price change (3M)
-0.4%
Price change (6M)
-17.8%
Price change (YTD)
-67.5%
Price change (1Y)
-81.0%
Trailing year
Price change (5Y)
-96.7%
52-week high
$2.24
52-week low
$0.32
Change from 52-week high
-81.0%
Change from 52-week low
+32.0%
Annualized volatility
102.4%
Annualized volatility (3M)
65.8%
Beta
1.7
RSI (14D)
54.1
Price vs SMA 50
+12.7%
Price vs SMA 200
-37.2%
Avg volume (3M)
272,059
Relative volume
0.3
Average dollar volume
$108,901

Company

3 metrics
Sector
Basic Materials
Industry
Agricultural Inputs
Shares outstanding
63.82M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
0.1×
reciprocal yield 1,125.0%
P / book
0.3
reciprocal yield 292.0%
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
0.3
reciprocal yield 312.8%
Earnings yield
-915.4%

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-05-12

Profitability

9 metrics
Gross margin
39.3%
Operating margin
-1.4%
Trailing 12 months
Net margin
-16.5%
Gross profit (TTM)
$115.60M
Operating profit (TTM)
−$4.24M
Net income (TTM)
−$56.37M
Trailing 12 months
Diluted EPS (TTM)
$-3.78
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$4.20

Growth

11 metrics
Revenue growth YoY
-25.3%
Year over year
Net income growth YoY
-1,396.1%
Revenue (TTM)
$294.42M
Trailing 12 months
EPS growth YoY
-125,473.9%
Shares change YoY
+3.9%
Year over year · more shares
Revenue CAGR (3Y)
+0.0%
Revenue CAGR (5Y)
+14.1%
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)
+42.0%

Quality

14 metrics
Return on equity
-21.8%
Return on assets
-7.7%
Debt / equity
Current ratio
0.9
EBITDA (TTM)
Free cash flow (TTM)
Quick ratio
0.7
Interest coverage
-0.1
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Cash & equivalents
$11.06M
Total assets
$560.36M
Total debt

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$81.87M
Capital expenditures (TTM)
$3.51M
R&D (TTM)
$16.60M
SG&A (TTM)
Stock compensation (TTM)
$3.58M
R&D / revenue
5.6%
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
29
13F filer change QoQ
-4
Institutional ownership
13.5%

Short interest

3 metrics
Short interest
0.5%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
37 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 1769484 CUSIP G1117K114 13F (30d) 19 filings 19 filers Visit website Investor relations